• Why Acute Myeloid Leukemia Is Sensitive to Mitocans

  2026-08-31

  Panina et al. identify acute myeloid leukemia as unusually sensitive to mitochondrial-targeting drugs and connect this vulnerability to defects in mitochondrial metabolism and respiratory coupling. The study further shows that combining the mitochondrial uncoupler CCCP with the glycolytic inhibitor 2-deoxyglucose produces selective anti-leukemia effects, including in primary AML cells.

• Triptolide (PG490): Applied Research Workflows

  2026-08-31

  Build mechanism-led assays with Triptolide (PG490), from nanomolar ovarian cancer invasion studies to transcriptional and inflammatory pathway analysis. This guide connects practical DMSO handling, orthogonal readouts, and the latest AhR–RBX1–HSF1 findings to help researchers distinguish pathway-specific effects from general cytotoxicity.

• BMS-345541 Hydrochloride: IKK Biology to Translation

  2026-08-30

  BMS-345541 hydrochloride offers a selective way to interrogate IKK–NF-κB signaling, while recent airway-stent research shows why inflammation must be evaluated alongside angiogenesis, fibrosis, and microbial stress. This article translates those findings into practical assay and translational strategy.

• Baicalin Methyl Ester: Reading Barrier Biology

  2026-08-29

  Baicalin methyl ester is an esterified derivative of baicalin with a useful mechanistic profile for intestinal barrier studies. This article presents a triangulation framework linking compound identity, P65-associated signaling, epithelial junctions, and assay interpretation.

• STING, CD40, and TLS in ESCC: Mechanistic Insights

  2026-08-28

  A 2025 study identifies tertiary lymphoid structures as favorable prognostic features in treatment-naïve esophageal squamous cell carcinoma and connects them with IRF4-positive tumor-infiltrating B cells. Its mechanistic model proposes that CD40 and STING compete for TRAF2, engaging non-canonical NF-κB signaling to promote IRF4 expression and B-cell activation.

• Z-YVAD-FMK for Caspase-1 Pathway Research

  2026-08-28

  Z-YVAD-FMK is a cell-permeable, irreversible caspase-1 inhibitor for separating pyroptotic signaling from apoptosis, inflammasome output, and nonspecific loss of viability. This workflow-focused guide shows how to use it in NSCLC, Caco-2, and inflammatory models while avoiding common interpretation and solubility errors.

• VX-745: Reliable p38α MAPK Assay Workflows

  2026-08-27

  This scenario-based guide explains how VX-745 (SKU A8686) can support interpretable cell viability, proliferation, cytokine, and cytotoxicity studies. It covers mechanism, solvent compatibility, pilot design, data interpretation, and practical criteria for selecting a reliable research-grade p38α MAPK inhibitor.

• Astrocytic GAT-3 and Dentate Gyrus Memory

  2026-08-27

  The reference study shows that astrocytic GAT-3 converts GABA uptake into a calcium-dependent signal that enhances dentate gyrus excitatory transmission and supports contextual fear-memory formation. Its combination of electrophysiology, optogenetics, immunohistochemistry, and behavioral testing provides a framework for separating transporter-driven astrocyte signaling from conventional postsynaptic GABA inhibition.

• NBC19: A Translational Lens on NLRP3 Biology

  2026-08-26

  CAMLs are emerging as clinically relevant, myeloid-like indicators of tumor progression, but the inflammatory mechanisms that support their biology remain unresolved. This thought-leadership perspective explains how NBC19, an NLRP3 inflammasome inhibitor, can help translational researchers test the relationship between NLRP3 activity, IL-1β signaling, and cancer-associated macrophage-like phenotypes without confusing mechanistic hypotheses with clinical evidence.

• GW 6471: A PPARα Antagonist for Mechanistic Studies

  2026-08-26

  GW 6471 is a small molecule PPARα antagonist used to probe transcriptional control of lipid metabolism and related disease mechanisms. Its reported IC50 is approximately 0.24 μM, while zebrafish toxicology evidence supports antagonist-based interrogation of PPAR-mediated liver injury.

• Merimepodib (VX-497) Workflow Guide

  2026-08-25

  Merimepodib (VX-497) gives researchers a reversible way to interrogate IMPDH-dependent guanine nucleotide biosynthesis in antiviral, lymphocyte, and cell-proliferation assays. This practical guide connects compound handling with PEDV host-dependency findings, assay controls, and troubleshooting strategies.

• Five-Element Nanoparticles for Stable Lung mRNA Delivery

  2026-08-25

  The reference study introduces five-element nanoparticles (FNPs) that combine helper poly(β-amino ester) polymers with DOTAP to improve lung-directed mRNA delivery and formulation stability. Its most practical finding is that lyophilized FNP formulations remained stable at 4 °C for at least six months, suggesting a route toward less demanding storage of extrahepatic mRNA delivery systems.

• PD 173074 Workflow for FGFR1 Research

  2026-08-24

  PD 173074 provides a practical way to separate FGFR1-driven signaling from broader kinase or cytotoxic effects in biochemical, cellular, and angiogenesis assays. This guide converts its nanomolar FGFR1 activity and methylation-linked HNSCC findings into reproducible workflows, dose-selection strategies, and troubleshooting decisions.

• cgSHAPE-seq Maps SARS-CoV-2 RNA Degrader Binding

  2026-08-24

  This Nature Communications study introduces cgSHAPE-seq, a sequencing-based strategy that identifies where small molecules bind structured RNA. Applied to the SARS-CoV-2 5′ untranslated region, the method located a bulged guanosine in SL5 and guided development of an RNase L-recruiting chimera that inhibited viral replication in cultured lung epithelial carcinoma cells.

• WSP-5 and the Hidden H2S Axis in Diabetic Hearts

  2026-08-23

  A translational perspective on how WSP-5, or Washington State Probe-5, can connect hydrogen sulfide biology with live-cell evidence in diabetic cardiomyopathy. The article combines mechanistic interpretation of H2S deficiency and ER stress with practical guidance for disease modeling, assay validation, and therapeutic research.

8464 records 1/565 page Next 12345 下5页 Last page